Maxigen Biotech (Taiwan) Market Value
| 1783 Stock | TWD 44.60 1.15 2.65% |
| Symbol | Maxigen |
Maxigen Biotech 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Maxigen Biotech's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Maxigen Biotech.
| 11/06/2023 |
| 11/30/2024 |
If you would invest 0.00 in Maxigen Biotech on November 6, 2023 and sell it all today you would earn a total of 0.00 from holding Maxigen Biotech or generate 0.0% return on investment in Maxigen Biotech over 390 days. Maxigen Biotech is related to or competes with Phytohealth Corp, Orient Pharma, and Yung Zip. Maxigen Biotech Inc. engages in the development, manufacture, and marketing of biomedical and cosmeceutical skincare pro... More
Maxigen Biotech Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Maxigen Biotech's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Maxigen Biotech upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.15) | |||
| Maximum Drawdown | 6.36 | |||
| Value At Risk | (2.32) | |||
| Potential Upside | 2.65 |
Maxigen Biotech Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Maxigen Biotech's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Maxigen Biotech's standard deviation. In reality, there are many statistical measures that can use Maxigen Biotech historical prices to predict the future Maxigen Biotech's volatility.| Risk Adjusted Performance | (0.03) | |||
| Jensen Alpha | (0.05) | |||
| Total Risk Alpha | (0.28) | |||
| Treynor Ratio | 0.4837 |
Maxigen Biotech Backtested Returns
Maxigen Biotech has Sharpe Ratio of -0.045, which conveys that the firm had a -0.045% return per unit of risk over the last 3 months. Maxigen Biotech exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please verify Maxigen Biotech's Standard Deviation of 1.29, risk adjusted performance of (0.03), and Mean Deviation of 0.8779 to check out the risk estimate we provide. The company secures a Beta (Market Risk) of -0.14, which conveys not very significant fluctuations relative to the market. As returns on the market increase, returns on owning Maxigen Biotech are expected to decrease at a much lower rate. During the bear market, Maxigen Biotech is likely to outperform the market. At this point, Maxigen Biotech has a negative expected return of -0.0594%. Please make sure to verify Maxigen Biotech's value at risk, skewness, and the relationship between the maximum drawdown and potential upside , to decide if Maxigen Biotech performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.61 |
Good predictability
Maxigen Biotech has good predictability. Overlapping area represents the amount of predictability between Maxigen Biotech time series from 6th of November 2023 to 19th of May 2024 and 19th of May 2024 to 30th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Maxigen Biotech price movement. The serial correlation of 0.61 indicates that roughly 61.0% of current Maxigen Biotech price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.61 | |
| Spearman Rank Test | 0.44 | |
| Residual Average | 0.0 | |
| Price Variance | 4.23 |
Maxigen Biotech lagged returns against current returns
Autocorrelation, which is Maxigen Biotech stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Maxigen Biotech's stock expected returns. We can calculate the autocorrelation of Maxigen Biotech returns to help us make a trade decision. For example, suppose you find that Maxigen Biotech has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Maxigen Biotech regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Maxigen Biotech stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Maxigen Biotech stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Maxigen Biotech stock over time.
Current vs Lagged Prices |
| Timeline |
Maxigen Biotech Lagged Returns
When evaluating Maxigen Biotech's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Maxigen Biotech stock have on its future price. Maxigen Biotech autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Maxigen Biotech autocorrelation shows the relationship between Maxigen Biotech stock current value and its past values and can show if there is a momentum factor associated with investing in Maxigen Biotech.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Maxigen Stock Analysis
When running Maxigen Biotech's price analysis, check to measure Maxigen Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Maxigen Biotech is operating at the current time. Most of Maxigen Biotech's value examination focuses on studying past and present price action to predict the probability of Maxigen Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Maxigen Biotech's price. Additionally, you may evaluate how the addition of Maxigen Biotech to your portfolios can decrease your overall portfolio volatility.